| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 35.43 | 29.6% | 57.5% |
| Total Income | 45.58 | 18.5% | 66.1% |
| Expenditure | 30.94 | 6.3% | 107.6% |
| PBT | 14.65 | 45.4% | 16.8% |
| Net Profit | 9.80 | 56.3% | 22.0% |
| OPM | 23.97% | 19.16pp | 11.24pp |
| NPM | 21.51% | 18.61pp | 7.78pp |
| EPS | 11.44 | 56.3% | 22.0% |
3B BlackBio Dx: FY26 Revenue ₹9727.50 Lakhs
29 May 2026 · 29 May, 3:45 pm
Summary
38 BLACKBTO DX LTD reported a mixed financial performance for the quarter and full financial year ended March 31, 2026. The company's revenue from operations saw a modest increase of 7.00% year-on-year for Q4 FY26, reaching ₹24.63 crore, contributing to a full-year revenue growth of 7.45% to ₹97.28 crore. However, profit for Q4 FY26 declined by 19.45% to ₹7.45 crore, while the full-year profit demonstrated a slight improvement of 3.69% to ₹49.32 crore. The Board recommended a final dividend of ₹5.00 per equity share for FY26, subject to shareholder approval, and the financial results received an unmodified audit opinion.
Key Highlights
- 1
Revenue from operations for the quarter ended March 31, 2026, increased by 7.00% year-on-year to ₹24.63 crore.
- 2
For the full financial year 2026, revenue from operations grew by 7.45% to ₹97.28 crore.
- 3
The company reported a profit for the period of ₹7.45 crore for Q4 FY26, which is a decline of 19.45% compared to ₹9.24 crore in Q4 FY25.
- 4
Full-year profit for FY26 stood at ₹49.32 crore, reflecting a modest growth of 3.69% from ₹47.56 crore in FY25.
- 5
Basic earnings per equity share for FY26 slightly improved to ₹57.56 from ₹55.51 in FY25.
- 6
The Board of Directors recommended a final dividend of 50%, equating to ₹5.00 per equity share of ₹10/- each, for the financial year ended March 31, 2026.
- 7
The Statutory Auditors issued an unmodified opinion on the audited standalone and consolidated financial results for the period.
Informational and educational content only. Not investment advice.